Streetbeat News

Revenues

ABT

The FDA has approved Abbott Laboratories' TriClip, a transcatheter edge-to-edge repair system designed for treating tricuspid regurgitation (TR) without the need for open-heart surgery. This approval is based on the TRILUMINATE Pivotal trial, which showed that 90% of patients experienced significant improvement in their TR grade, with a highly favorable safety profile. TriClip, leveraging technology similar to Abbott's MitraClip, is expected to see high sales growth and has been approved in over 50 countries, treating over 10,000 people.

Portfolio Pulse from Vandana Singh

April 02, 2024 | 5:00 pm

ULCC

Frontier shares are experiencing an uptick following reports that the airline is concentrating its efforts on expanding in high-fare markets, which could potentially enhance its revenue and profitability.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 4:54 pm

STRO

Sutro Biopharma Inc (NASDAQ:STRO) shares dropped 2.8% to $5.18 after announcing a $75 million underwritten offering of 14,478,764 shares at $5.18 each. The offering, closing around April 4, is led by healthcare-focused investors. Funds will support research, development, and potential acquisitions. BofA Securities is the book-runner. Wall Street views STRO as an Outperform, with a notable analyst predicting a 33.33% fall. The stock has risen 14.01% in the past 3 months, with revenue up 1217.44% over the past year.

Portfolio Pulse from Henry Khederian

April 02, 2024 | 4:46 pm

CNX

CNX Resources (NYSE:CNX) has been evaluated by 5 analysts over the last three months, showing a shift towards a more neutral stance. The average 12-month price target for CNX has increased to $21.8, up 5.83% from $20.60. Analysts from Roth MKM, Truist Securities, Piper Sandler, and Mizuho have adjusted their ratings and price targets, reflecting a nuanced view of CNX's market position. Despite a significant revenue decline of -54.31% as of December 31, 2023, CNX demonstrates strong financial health with a high net margin of 130.93%, an ROE of 12.36%, and an ROA of 6.0%, alongside a conservative debt-to-equity ratio of 0.54.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 4:01 pm

ONB

Analyst ratings for Old National (NASDAQ:ONB) show varied sentiments, with recent adjustments reflecting a mix of maintained and lowered stances. The average 12-month price target is now $20.0, down from $21.00, indicating a 4.76% decrease. Old National Bancorp, a financial services company with nearly $10 billion in assets, faces challenges in market capitalization and revenue growth, but excels in net margin, ROE, and ROA, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 4:01 pm

DOW

Over the past three months, 8 analysts have provided diverse opinions on Dow (NYSE:DOW), with recent assessments showing a shift towards a more bullish stance. The average 12-month price target has been raised to $58.75, reflecting a 2.0% increase from the previous target. Analysts' actions, including rating upgrades and price target adjustments, indicate changing market dynamics and Dow's performance. Despite a -10.44% decline in revenue growth and a negative net margin, Dow's financial strength is highlighted by its exceptional ROE, ROA, and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 4:00 pm

SPGI

S&P Global (NYSE:SPGI) has received consistently 'Somewhat Bullish' ratings from 5 analysts over the past quarter, with a notable increase in the average 12-month price target to $483.0 from $451.0, indicating a positive outlook. The company's financial performance shows a strong market presence and revenue growth, but challenges in profitability and asset utilization. Analysts from firms like Oppenheimer, BMO Capital, RBC Capital, and Raymond James have maintained or raised their 'Outperform' ratings, reflecting optimism about the company's future performance.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 4:00 pm

FXI

SPY

U.S. Treasury Secretary Janet Yellen is set to discuss the global economic impacts of Chinese industrial overcapacity in upcoming meetings with Chinese officials. Yellen aims to gain insights into China's property market developments and the country's latest growth targets.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 3:42 pm

GETY

Getty Images Holdings, Inc. (NYSE:GETY) has acquired Motorsport Images, enhancing its motorsport industry presence and expanding customer offerings. The acquisition includes Motorsport Images' extensive archive and talent. Getty Images' CEO highlighted the addition of iconic imagery and video to their motorsport offerings. Motorsport Images' content will be available on Getty's platform from May 3, 2024. Despite the acquisition, GETY shares dropped by 1.95% to $4.02. The company reported quarterly sales of $225.94 million, surpassing analyst estimates, and projects fiscal year 2024 revenue between $928 million and $947 million.

Portfolio Pulse from Nabaparna Bhattacharya

April 02, 2024 | 3:37 pm

HSBC

HSBC Holdings Plc is considering the sale of its wealth-management, custody, and fund administration units in Germany as part of its strategy to focus more on its core Asian operations. The review is in its early stages, and there's no guarantee of a sale. This move aligns with HSBC's recent trend of exiting non-core businesses and markets, including North America and French retail operations. The bank's German fund administration business, Inka, manages approximately €400 billion in assets. HSBC's German private banking activities generated about $90 million in revenue in 2023.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 3:23 pm